Adalvo Ltd., Orion Corporation Orion Pharma, Orion Corporation Orion Pharma, Saneca Pharmaceuticals a.s.

This medicine is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat deep vein thrombosis and pulmonary embolism, as well as to prevent the recurrence of clots.

Dosage form: tablets, film-coated

ATC: B01AF01

In adults, it is used to prevent strokes and blood clots (in atrial fibrillation) and to treat and prevent blood clots in the veins of the legs and lungs. In children and adolescents (weighing more than 30 kg), it is used to treat blood clots in the veins or lungs.

Dosage form: tablets, film-coated

ATC: B01AF01

In adults, it is used to prevent strokes and blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (over 30 kg), it is used for the treatment and prevention of blood clots in the veins or lungs.

Dosage form: tablets, film-coated

ATC: B01AF01